Kinnevik B Stock - Analyst consensus and long-term holdings in focus

Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 15:26 UTC. Details in the imprint.

Kinnevik B (SE0015810247) remains a key Swedish listed investment company for investors following Nordic growth names. With no new company announcement or major newswire report today, the focus shifts to analyst consensus and the group’s long-term portfolio approach.

What analysts currently say

There is no fresh broker note or rating change on Kinnevik B filed today with major news services or the company’s investor relations site. Recent coverage instead remains centered on the group’s listed holdings and net asset value.

Consensus data from major financial portals shows a mix of Buy and Hold recommendations on Kinnevik B, with target prices typically framed against the underlying portfolio companies’ valuations and a discount to net asset value.

How the long-term portfolio is structured

Kinnevik describes itself as a sector-focused growth investor with a portfolio concentrated in digital consumer businesses, healthcare and other long-term themes. The company highlights a strategy of backing scalable platforms, often in Northern Europe and selected global markets.

The largest listed holdings have in recent years included telemedicine and digital health providers such as Teladoc Health and regional champions like Tele2, alongside stakes in high-growth unlisted companies in consumer and healthcare segments.

How the company makes money

Kinnevik’s business model is to deploy capital into a concentrated portfolio of growth companies and realize value over time through share price appreciation, exits, and occasional dividends or distributions from its holdings. Its main “product” is effectively its actively managed investment portfolio.

Where the stock trades today

The shares of Kinnevik B (SE0015810247) trade on Nasdaq Stockholm; a reliable real-time price and market capitalization could not be independently verified for this report’s timestamp.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.